Прогностическая значимость экспрессии генов монорезистентности в опухоли больных немелкоклеточным раком легкого; Перспективы развития фундаментальных наук; Т. 4 : Биология и фундаментальная медицина
| Parent link: | Перспективы развития фундаментальных наук=Prospects of Fundamental Sciences Development: сборник научных трудов XIV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 25-28 апреля 2017 г./ Национальный исследовательский Томский политехнический университет (ТПУ) ; под ред. И. А. Курзиной, Г. А. Вороновой.— , 2017 Т. 4 : Биология и фундаментальная медицина.— 2017.— [С. 43-45] |
|---|---|
| Autore principale: | |
| Altri autori: | , |
| Riassunto: | Заглавие с экрана A significant role in the development of lung tumor resistance to drug therapy play so called mono resistance genes that determine resistance/sensitivity of tumor cells to distinct chemotherapeutic agents, they include BRCA1, RRM1, ERCC1, TOP1, TOP2a, TUBB3, TYMS, ABCC5 genes. It is shown that the use of these biomarkers as criteria to appoint the adequate postoperative chemotherapy is associated with the forecast. However in the course of neoadjuvant chemotherapy change the expression profile of these genes can occur, which can lead to misinterpretation of results. In this regard perspective is the development of new relevant prognostic factors, which take into account occurred molecular genetic alterations in lung tumors after preoperative therapy. We presented the results of the combined treatment of 52 patients with NSCLC IIA - IIIB stage, based on the analysis of chemotherapy resistance/sensitivity gene expression for appointment the suitable drugs. As a result, we have shown that expression of ERCC1, TUBB3, RRM1, ABCC5 and TYMS genes are the prognostic factor in the lung tumor after neoadjuvant chemotherapy. |
| Lingua: | russo |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | http://earchive.tpu.ru/handle/11683/44846 |
| Natura: | Elettronico Capitolo di libro |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=624978 |
MARC
| LEADER | 00000naa2a2200000 4500 | ||
|---|---|---|---|
| 001 | 624978 | ||
| 005 | 20260806142759.0 | ||
| 035 | |a (RuTPU)RU\TPU\conf\24238 | ||
| 035 | |a RU\TPU\conf\24234 | ||
| 090 | |a 624978 | ||
| 100 | |a 20171205d2017 k y0rusy50 ca | ||
| 101 | 0 | |a rus | |
| 102 | |a RU | ||
| 135 | |a drcn ---uucaa | ||
| 181 | 0 | |a i | |
| 182 | 0 | |a b | |
| 200 | 1 | |a Прогностическая значимость экспрессии генов монорезистентности в опухоли больных немелкоклеточным раком легкого |d Prognostic significance of monoresistance gene expression in the tumors of patients with non-small cell lung cancer |f И. В. Дерюшева, М. М. Цыганов, Е. О. Родионов |g науч. рук. М. М. Цыганов | |
| 203 | |a Текст |c электронный | ||
| 300 | |a Заглавие с экрана | ||
| 320 | |a [Библиогр.: с. 45 (6 назв.)] | ||
| 330 | |a A significant role in the development of lung tumor resistance to drug therapy play so called mono resistance genes that determine resistance/sensitivity of tumor cells to distinct chemotherapeutic agents, they include BRCA1, RRM1, ERCC1, TOP1, TOP2a, TUBB3, TYMS, ABCC5 genes. It is shown that the use of these biomarkers as criteria to appoint the adequate postoperative chemotherapy is associated with the forecast. However in the course of neoadjuvant chemotherapy change the expression profile of these genes can occur, which can lead to misinterpretation of results. In this regard perspective is the development of new relevant prognostic factors, which take into account occurred molecular genetic alterations in lung tumors after preoperative therapy. We presented the results of the combined treatment of 52 patients with NSCLC IIA - IIIB stage, based on the analysis of chemotherapy resistance/sensitivity gene expression for appointment the suitable drugs. As a result, we have shown that expression of ERCC1, TUBB3, RRM1, ABCC5 and TYMS genes are the prognostic factor in the lung tumor after neoadjuvant chemotherapy. | ||
| 461 | 1 | |0 (RuTPU)RU\TPU\conf\21388 |t Перспективы развития фундаментальных наук |l Prospects of Fundamental Sciences Development |o сборник научных трудов XIV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 25-28 апреля 2017 г. |o в 7 т. |f Национальный исследовательский Томский политехнический университет (ТПУ) ; под ред. И. А. Курзиной, Г. А. Вороновой |d 2017 | |
| 463 | 1 | |0 (RuTPU)RU\TPU\conf\21393 |t Т. 4 : Биология и фундаментальная медицина |v [С. 43-45] |d 2017 | |
| 510 | 1 | |a Prognostic significance of monoresistance gene expression in the tumors of patients with non-small cell lung cancer |z eng | |
| 610 | 1 | |a электронный ресурс | |
| 610 | 1 | |a профилактика | |
| 610 | 1 | |a хирургия | |
| 610 | 1 | |a химиотерапия | |
| 610 | 1 | |a онкология | |
| 610 | 1 | |a прогнозы | |
| 610 | 1 | |a опухоли | |
| 700 | 1 | |a Дерюшева |b И. В. | |
| 701 | 1 | |a Цыганов |b М. М. | |
| 701 | 1 | |a Родионов |b Е. О. | |
| 702 | 1 | |a Цыганов |b М. М. |4 727 | |
| 801 | 2 | |a RU |b 63413507 |c 20171211 |g RCR | |
| 856 | 4 | |u http://earchive.tpu.ru/handle/11683/44846 | |
| 942 | |c CF | ||